<DOC>
	<DOCNO>NCT01895894</DOCNO>
	<brief_summary>Idiopathic nephrotic syndrome generally responsive steroid therapy , patient need immunosuppressant reduce steroid dependency . The long-term use restrict due adverse effect cyclosporine , hypertension nephrotoxicity . Mycophenolate mofetil steroid-dependent nephrotic syndrome report similar efficacy fewer undesirable effect drug mainly observational study . To determine efficacy mycophenolate mofetil management steroid-dependent nephrotic syndrome , investigator design prospective randomize control study .</brief_summary>
	<brief_title>Mycophenolate Mofetil Pediatric Steroid Dependent Nephrotic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Nephrotic Syndrome</mesh_term>
	<mesh_term>Nephrosis</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Steroiddependent patient calcineurin inhibitor continuously 1 year complete remission Hereditary secondary nephrotic syndrome Estimated glomerular filtration rate ( GFR ) &lt; 60 mg/min/1.73 m^2 Body weight &lt; 16 kg leukocytopenia ( absolute neutrophil count &lt; 2000/mm^3 ) anemia ( Hct &lt; 25 % ) Severe gastrointestinal disease chronic acute active infection ( e.g . hepatitis B , C , herpes , varicella zoster ) prior live vaccine inoculation within 6 week ( study enrollment ) GOT/GPT elevation hyperbilirubinemia malignant disease Pregnant Breast feed Previous history mycophenolate mofetil use Participation therapeutic trial within recent 3 month Deficiency enzyme hypoxanthineguanine phosphoribosyltransferase</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>24 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Mycophenolate mofetil</keyword>
	<keyword>Immunosuppressive Agents</keyword>
	<keyword>Nephrosis</keyword>
</DOC>